Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
131 Cards in this Set
- Front
- Back
Used before ATP when intensively exercising |
phosphocreatine |
|
3 irreversivle steps catalysed by (glycolysis) |
hexokinase 6-phospho-frukto-1-kinase (PFK1) pyruvate kinase |
|
3 irreversible steps catalysed by (gluconeogenesis) |
glucose 6-phosphatase fructose 1,6-bisphosphatase phosphoenolpyruvate carboxykinase |
|
what's released by muscle and converted to what |
alanine and lactate, both go to pyruvate and glucose vio gluconeogenesis |
|
Control of enzyme activity |
Substrate level control cooperativity Allosteric effectors Substrate cycles Covalent modifications Control through changes in enzyme concentration |
|
exception: which flux-controlling enzyme is controlled by changes in substrate concentration Where's it found, how |
glucokinase, in beta cells and liver. Has high Km for glucose, comparable to [glu] in plasma (5mM) |
|
another name for glucokinase |
hexokinase IV |
|
beta pancreatic cells and glucose |
glucose ↑→glucokinase activity ↑→ glycolytic flux ↑→insulin secretion |
|
Experiment to test for hexokinase control by glucose |
Expressed yeast hexokinase in mice (lower Km), so active even at low glu concentrations. Transgenic mice had lower glucose elvels and higher insulin concentration. |
|
sup with plasma membrane of beta and liver cells |
freely permeable to glucose: lots of insulin-independent GLUT 2 transporters - [glu] in and out close to equilibrium |
|
two cooperativity models |
Monod-Wyman-Changeux Koshland-Nemethy-Filmer Concerted and Sequential |
|
Hill coefficient |
n in % saturation with ligand L^n/(Kd+L^n) |
|
for higher hill coefficients |
sigmoidal curve is ssteeper/ultrasensitive |
|
exception to the rule that regulatory enzymes show cooperativity wrt substrate binding and controlled by allosteric effectors |
muscle hexokinase, which is allosterically inhibited by glu6phosphate but has only one subunit and does not show cooperativity wrt substrate binding. |
|
what controls glycolysis |
level of glucose uptake heokinase pfk1 pyruvate kinase |
|
PFK1 allosteric inhibitor what is it relieved by |
ATP (also substrate) AMP |
|
pyruvate kinase allosteric activator |
fructos 1,6-bisphosphate |
|
effects of increase in PFK1 activity |
→F16BP↑ (allosteric actiator of pyruvate kinase) →Glu6P↓ (inhibitor of hexocinase) |
|
Substrate cycles. elaborate |
Phosphofruktokinase and fructose 16biphosphatase. substrates circled around using ATP regulatory signal comes in (eg AMP activates PFK1 and inhibits F16BPase) and the throughput is much increased. |
|
phosphorylation sites |
serine threonine (tyrosine) |
|
how many ser/threonine and tyrosine in humans |
428 ser/threonine 90tyr |
|
covalent regulatory modifications |
phosphorylation and acetylation |
|
what can be acetylated |
lysine, uses acetyl CoA as donor |
|
glycogen synthase control (muscle) |
phosphorylation on several serines phosph inhibits activity by increasing Km for substrate and Kd for activator Kds for inhibitors ATP and Pi reduced |
|
substrate of glycogen synthase (muscle) |
UDP-glucose |
|
activator for glycogen synthase (muscle) |
glucose-6-phosphate |
|
metabolism-related phosphatase (muscle) |
protein phosphatase 1 responsible for the removal of all phosphates involved in the regulation of glycogen metabolism |
|
what does PP1 do (muscle) |
decreases the rate of glycogen breakdown and accelerates glycogen synthesis |
|
catalytic sub of pp1(muscle) |
low affinity for glycogen particles - ineffective |
|
glycogen particles have (muscle) |
phosphorylase and glycogen synthase |
|
what makes PP1 go to glycogen particle (muscle) |
association with glycogen-binding/G subunit |
|
Phosphorylation of G subunit? (muscle) |
By PKA Prevents binding to catal subunit of PP1 Inactivates PP1 By Insulin-Sensitive Protein kinase at different site activates PP1 |
|
inhibition of PP1 (muscle) |
inhibitor when phosphorylated by PKA inhibits phosphatase |
|
PP1 activator (muscle) |
insulin |
|
ho regulation of liver phosphorylase differs from muscle |
liver: AMP does not activate the b form and the level of a form is regulated by glucose binding. |
|
glucose sensor in liver |
phosphorylas a |
|
production of glucose |
glycogenolysis |
|
how many phosphorylase a per phosphatase |
10 |
|
Advantages of protein phosphorylation for control of enzyme activity |
Signal amplification coordination increased sensitivity |
|
effect of glucagon and beta-adrenergic agonists in liver |
adenylate cyclase*→cAMP↑→PKA*→phosphorylation of: pyruvate kinase 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase at serine residues |
|
6PF-2-K/Fru-2,6-P2ase does what? (liver) |
inhibits the kinase and activates phosphatase |
|
consequence of activation of 6PF-2-K/Fru-2,6-P2ase (liver) |
fructose-2,6-bisphosphate concentration falls |
|
activator and inhibitor of what is fructose 2,6-bisphosphate (liver) |
activator of PFK1 inhibitor fru-1,6-P2ase |
|
result of activation of PFK1 and inhibition of fru-1,6-P2ase (liver) |
enhanced glycolysis, inhibited gluconeogenesis and increase of fructose 1,6 bisphosphate |
|
pyruvate kinase allosteric regulators (liver) |
inhibitors ATP and alanine activator fructose 16 bisphosphate |
|
phosphorylation of pyruvate kinase (liver) |
inhibits it by increasing Km for phosphoenolpyruvate decreasing activation by fructose-16 bisphosphate enhancing inhibition by ATP and alanine |
|
effect on Ca-linked hormones on gluconeogenesis is mediated by (liver) |
Ca-calmodulin-dependent PK catalysed phosphorylation of pyruvate kinase at serine and threonine |
|
how insulin reverses effects of stimulatory hormones on gluconeogenesis (liver) |
by enhancing low Km phosphodiesterase activity and lowering cAMP levels |
|
how cAMP activate glycolysis in muscle and inliver oppositely inhibits glycolysis and activates gluconeogenesis |
Muscle isoform of 6PF-2-K/Fru-2,6-P2ase and pyruvate kinase lack PKA phosphorylation site |
|
Response to adrenaline in heart wrt Fru-2,6-P2 |
adrenaline - Phosphorylation of 6PF-2-K/Fru-2,6-P2ase - rise in Fru-2,6-P2ase (liver: decrase in levels) - accelerate glycolysis |
|
PEPCK? |
Phosphoenolpyruvate carboxylatekinase |
|
PEPCK acetylation? (liver) |
enhanced by glucose decreased by amino acids promotes degradation |
|
Glucokinase regulation (liver) |
inhibited by protein binding NOT inhibited by G6P Fru6P binds regulatory P, reinforces inhibition, prevents futile cycle between glucose ang G6P |
|
activates glucokinase (liver) |
fructose 1 phosphate ensures Glucose and Fructose uptake |
|
Glut 1 |
nearly all mammalian cells, basal glu transport Km =1mM |
|
Glut 2 |
liver and pancreatic beta cells high Km for glu (15-20 mM) glu uptake rate proportional to blood glucose level |
|
Glut 3 |
nearly all mammalian cells, basal glu transport Km =1mM |
|
Glut4 |
Km 5mM recruited to the plasma membrane of muscle and fat cells by insulin promoting glucose uptake by these cells |
|
Insulin stimulates expression of |
PFK1, PK and 6PF-2-K/Fru-2,6-P2ase |
|
Glucagon vs expression |
inhibits PFK1, PK, 6PF-2-K/Fru-2,6-P2ase stimulates PEPCK and Fru-1,6-P2ase |
|
how long it takes to change enzyme concentration |
several hours |
|
what mediates the effect of cAMP on transcription (liver) |
CRE (cAMP response elements) 8bp palindromes |
|
what binds to CRE (liver) |
(cAMP response elements) CREB (cAMP response element binding protein) Leucine zipper |
|
How does CREB work(liver) |
(cAMP response element binding protein) dimerises through C-terminal leucine zipper brings together two basic DNA binding molecules that bind CRE |
|
What promotes dimerisation o CREB (liver) |
PKA - also enhances transcriptional activation |
|
Hormonal control of liver glucose metabolism |
transcriptional co-activator PGC-1 |
|
What does PGC-1 do |
induced in liver by fasting coordinate upregulation of PEPCK, G6Pase, Fru-1,6-P2ase gene expression |
|
transcription factor regulating Glu metabolism in liver |
Glucose-responsive transcription factor, |
|
ChREBP |
Carbohydrate response element binding protein helix-loop-helix leucine zipper, |
|
What ChREBP binds |
ChRE in L-type pyruvate kinase promoter DNA binding inhibited by phosphorylation by PKA and by AMPK |
|
Describe HIF-1 |
helix-loop-helix factor from alpha and beta subunits increases expression of genes encoding glycolytic enzymes |
|
effect of oxygen on HIF-1alpha interacts with what tumor suppressor protein |
•Prolyl-4-hydroxylase +O2 hydroxylates two prolines on the HIF-1α •Promoted interaction with von Hippel-Landau tumor supressor protein •Ubiquitin ligase recognises Hippel-Landau P •DESTRUCTION |
|
effect of oxygen on HIF-1α |
•Hydroxylation of aspargine •blocks interaction of C terminal domain with •p300/CBP transcriptional co-activators |
|
Tumors do what glycolysis |
aerobic glycolysis |
|
HIF-1 stabilises what and so? |
p53 → plays direct role as transcription factor in hypoxia |
|
mutant p53 stimulates transcription of what promoter |
HK2 (hexokinase)→ p53 has role in tumour metaobolism |
|
what induces HIF-1 expression |
v-SRC |
|
what does HIF-1 do |
turns on glycolysis and turns off flux to TCA cycle |
|
how HIF-1 cuts off stuff from TCA |
induces PDK1 (protein kinase) no Pion of E1 of PDH (pyruvate dehydrogenase) inactivated PDH |
|
how p53 inhibits glycolysis |
activates TIGAR de-Pases fru-2,6-bisphosphate inhibits glycolysis diverts flux into pentose phosphate pathway NADPH production which reduses ROS (reactive oxygen species) |
|
TIGAR |
TP53-induced glycolysis and apoptosis regulator has fru-2,6-bisphosphate activity |
|
tumors express what Pyruvate kinase |
splice isoform PKM2 |
|
competitive inhibitor of PKM2 |
phospho-tyrosine produced by growth factor signaling via tyrosine kinases when bound, releases activator fructose-1,6-bisphosphate buildup of upstream stuff → glucose diverted into lipid synthesis |
|
how's PKM2 involved in response to oxidative stress |
Cysteine is oxidised by H2O2 decreases PKM2 activity decreased glycolysis flux diverted into PPP increased phosphoenolpyruvate inhibits trioseposphate isomerase increases PPP more |
|
PGAM1 does what |
Phosphoglycerate mutase 1 3-phosphoglycerate to 2-phosphoglycerate |
|
Ox PPP starting G6P to nucleotides |
Glucose 6 phosphate → 6-phosphogluconate →(6Phosphogluconatemutase) →Ribose 5 phosphate →nucleotides |
|
PPP starting 3-phosphoglycerate |
3-Phosphoglycerate →(3-phosphoglycerate dehydrogenase)→p-PYR→serine→glycine→nucleotides |
|
How's PGAM1 expression regulated |
negatively by p53 |
|
PGAM1 regulating biosyntheis |
•regulates 3-PG and 2-PG levels •3-PG inhibits 6-Phosphogluconatedehydrogenase (no nucleotide synthesis ) •2-PG activates 3-Phosphoglycerate dehydrogenase (activates nu biosynthesis???) - provides feedback control to increase pathway through serine |
|
how they studied the intracellular environment |
cryogenic electron tomography vitrified sample thick (0.25-1.5 µm) |
|
thicknes of electron microscopy samples |
50-100nm |
|
resolution limit of cryo-TM |
4-5 nm protein complexes >400kDa 2nm prospect |
|
how's free cytosolic [ADP] mesured |
by measuring creatine kinase substrates: Creatine-P2- + MgADP- + ATP ↔ Creatine + MgATP2- And then Rearrange Keq stuff |
|
why's cytosolic ADP low in muscles |
compartmentation by binding: ADP binds actin |
|
ways of compartmentation |
by binding in cellular organelles metabolite gradients |
|
what's used as a probe for intracellular ATP concentration |
Firefly luciferise Km=mM for ATP luminescence used to report local glu concentration |
|
what promotes protein-protein interaction |
high P concentrations solvent exclusion effects |
|
What's substrate channelling |
enzymes complex, substrates pass between enzymes w/o equilibrating |
|
advantages of substrate channelling 6 |
high fluxes with low intermediates •Intermediates isolated from side reactions • unstable intermediates protected • unfavourable equilibria avoided •Faster response - reduction of lag times in transients between steady states • regulation of flux |
|
evidence for substrate channelling |
studies on isolated and non-isolated enzyme systems |
|
heksokinases in brain and muscle |
HKI brain HKII muscle |
|
coordination of initial step of glucose metabolism w/ mit ox ph |
glucose is phosphorylated using mit-generated ATP by hexokinase: Incubate w/ radact P and ATP: G6P will be rad active (with isolated mitochondria) |
|
positioning of Hexokinase |
bound to mitochondria, if displaced (by cell-permeable peptide containing HKII binding motif) causes mitochondrial membrane depolarisation, mitochondrial swelling and structural disruption of the cardiac tissue. Control peptide without effect |
|
where's creatine phosphate shuttle? |
creatine kinase is associated with myofibrillar M-band, coupled to the myofibrillar Mg2+ ATPase |
|
3 points on why the localisation of the enzyme is important for the creatine kinase system |
• acts as energy buffer maintaining concentrations of ATP, ADP and H during muscle contractions •maintain high local ATP/ADP at myofibrils - rapid ATP utilisation •energy shuttle - PC is better for diffusion than ATP/ADP |
|
Why's Phosphocreatine better for energy transport than ATP |
present at higher (local?) concentration |
|
How's PC 'shuttle' hypothesis proved |
mouse creatine kinase gene disrupted Muscles adapted by producing more bigger mitochondria - reduced diffusion distance |
|
Drosophila flight muscle localisation of stuff |
•glycerol 3-phosphate dehydrogenase (GPDH-1) •localised to the Z discs and M lines in D flight muscle •colocalisation of aldolase and glyceraldehyde 3-phosphate dehydrogenase |
|
Drosophila Gpdh null alleles |
No localisation of GAPDH and aldolase •localistion restored by plasmid expressing GPDH-1 (it has 3peptide at C term for localisation •localisation NOT restored by expression of GPDH-3 (w/o the thripeptide) •GPDH-3 had normal levels of the enzymes, but couldn't fly |
|
localised glycolysis in vascular endothelial cells |
•controls vessel sprouting •PFKFB3 has hiher kinase activity than P2ase •favours production of F2,6P2 - activation of glycolysis •relocated from perinuclear cytosol to lamellipodia protrusions in motile endothelial cells •co-locates with F-actin and other glycolytic enzymes •Mitochondria couldn't fit into the protrusions |
|
substrate channelling in vivo - examples |
•Hexokinase •Creatine phosphate 'shuttle' •GPDH-1 localisation in Drosophila •vessel sprouting in vascular endothelial cells •Aldolase mobilation from actin •Glycogen synthase and glucokinase on the move |
|
glycogen synthase possitioning in liver |
generally scattered migrates to the cell periphery and co-localises with actin when glucose's present |
|
glucokinase positioning in lvier |
with high glucose, glucokinase translocated from nucleus to periphery with glycogen synthase glycogen first deposited in the cell periphery |
|
glucokinase vs hexokinase vs glu-6-p in liver |
gluK & hexK raise G6P conc but only gluK increases glycogen synthesis, activates glycogen synthase more (deP more) |
|
Archean oceanic environment is good for 3 things |
•stabilising sugar phosphates •↑specificity of non-enzymatic pyruvate formation •accelerated glycolysis- and pentose phosphate-like non-enz reactions |
|
metabolic network? |
scale-free network where few hubs link it together |
|
degree of interconnectivity characterised by |
network diameter |
|
define network diameter |
shortest biochemical pathway averaged over all pairs of substrates |
|
approximate network diameter |
3 |
|
advantage of scale-free metabolic network |
allow perturbations to be rapidly transmitted |
|
elementary flux modes |
smallest sub-network enabling the metabolic system to operate at steady state |
|
network robustness vs number of elementary modes connecting metabolites |
increases - if something malfunctions, another enzyme can take over from another elementary mode |
|
yeast: main network robustness mechanism |
network redundancy through replication of the genes |
|
Isoenzymes vs robustness |
appear where high flux is needed duplicates permit selectively advantageous increase in flux rates |
|
pathway is usually in what? |
dynamic steady state |
|
methods for identifying flux controlling enzymes |
•enzymes with low Vmax •enzymes catalysing far from eq reactions (mass action ratio/Q<<Keq) •Look for cross-over points: [reag]↑ and [prod]↓ •Control points at the start of pathway or after branch points |
|
metabolic control analysis |
relates flux and intermediary metabolite levels to the activities of the component enzymes |
|
Flux control coefficient of an enzyme |
fractional change in pathway flux/fractional change in enzyme concentration sum of all in linear pathway =1 |
|
flux control coefficients' measurements in mit ox ph |
titrating enzymes' activities with inhibitors |
|
inhibitor of adenine nucleotide translocase |
carboxyatractyloside |
|
experiment to measure adenine nucleotide translocase flux control coefficient: two points to note |
flux control is distributed with all components showing some control •the distribution of control changes depending on the rate of respirtaion |